Probiotic strategies for the treatment and prevention of bacterial vaginosis

Bibliography

• Antonio MA, Hawes SE, Hillier SL. The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis 1999;180:1950-6
   PubMed Web of Science ®Google Scholar
• Zozaya-Hinchliffe M, Lillis R, Martin DH, Ferris MJ. Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol 2010;48:1812-19
   PubMed Web of Science ®Google Scholar
• Hummelen R, Macklaim J, Fernandes A, Deep sequencing of the vaginal microbiome in HIV patients. PLoS ONE 2010;5(8):e12078
   Google Scholar
• Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 2002;168:171-8
   PubMed Web of Science ®Google Scholar
• Reid G, Dols J, Miller W. Targeting the vaginal microbiota with probiotics as a means to counteract infections. Curr Opin Clin Nutr Metab Care 2009;12:583-7
   PubMed Web of Science ®Google Scholar
• Schwebke JR, Richey CM, Weiss HL. Correlation of behaviors with microbiological changes in vaginal flora. J Infect Dis 1999;180:1632-6
   PubMed Web of Science ®Google Scholar
• Keane FE, Ison CA, Taylor-Robinson D. A longitudinal study of the vaginal flora over a menstrual cycle. Int J STD AIDS 1997;8:489-94
   PubMed Web of Science ®Google Scholar
• Valore EV, Park CH, Igreti SL, Ganz T. Antimicrobial components of vaginal fluid. Am J Obstet Gynecol 2002;187:561-8
   PubMed Web of Science ®Google Scholar
• Cadieux PA, Burton J, Devillard E, Reid G. Lactobacillus by-products inhibit the growth and virulence of uropathogenic Escherichia coli. J Physiol Pharmacol 2009;60(Suppl 6):13-8
   PubMedGoogle Scholar
• Eschenbach DA, Thwin SS, Patton DL, Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis 2000;30:901-7
   PubMed Web of Science ®Google Scholar
• Srinivasan S, Liu C, Mitchell CM, Temporal variability of human vaginal bacteria and relationship with bacterial vaginosis. PLoS One 2010;5:e10197
   PubMed Web of Science ®Google Scholar
• Heinemann C, Reid G. Vaginal microbial diversity among postmenopausal women with and without hormone replacement therapy. Can J Microbiol 2005;51:777-81
   PubMed Web of Science ®Google Scholar
• Chan RC, Bruce AW, Reid G. Adherence of cervical, vaginal and distal urethral normal microbial flora to human uroepithelial cells and the inhibition of adherence of gram-negative uropathogens by competitive exclusion. J Urol 1984;131:596-601
   PubMed Web of Science ®Google Scholar
• Zhou X, Brown CJ, Abdo Z, Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J 2007;1:121-33
   PubMed Web of Science ®Google Scholar
• Hitti J, Nugent R, Boutain D, Racial disparity in risk of preterm birth associated with lower genital tract infection. Paediatr Perinat Epidemiol 2007;21:330-7
   PubMed Web of Science ®Google Scholar
• Peipert JF, Lapane KL, Allsworth JE, Bacterial vaginosis, race, and sexually transmitted infections: does race modify the association? Sex Transm Dis 2008;35:363-7
   PubMed Web of Science ®Google Scholar
• Hillier SL. The complexity of microbial diversity in bacterial vaginosis. N Engl J Med 2005;353:1886-7
   PubMed Web of Science ®Google Scholar
• Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005;353:1899-911
   PubMed Web of Science ®Google Scholar
• Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 1991;29:297-301
   PubMed Web of Science ®Google Scholar
• Reid G, Burton J, Hammond J-A, Bruce AW. Nucleic acid based diagnosis of bacterial vaginosis and improved management using probiotic lactobacilli. J Med Food 2004;7:223-8
   PubMed Web of Science ®Google Scholar
• Bradshaw CS, Morton AN, Garland SM, Evaluation of a point-of-care test, BVBlue, and clinical and laboratory criteria for diagnosis of bacterial vaginosis. J Clin Microbiol 2005;43:1304-8
   PubMed Web of Science ®Google Scholar
• Payne SC, Cromer PR, Stanek MK, Palmer AA. Evidence of African-American women's frustrations with chronic recurrent bacterial vaginosis. J Am Acad Nurse Pract 2010;22:101-8
   PubMed Web of Science ®Google Scholar
• Klebanoff MA, Schwebke JR, Zhang J, Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol 2004;104:267-72
   PubMed Web of Science ®Google Scholar
• Gomez LM, Sammel MD, Appleby DH, Evidence of a gene-environment interaction that predisposes to spontaneous preterm birth: a role for asymptomatic bacterial vaginosis and DNA variants in genes that control the inflammatory response. Am J Obstet Gynecol 2010;202:386. e1-6
   PubMed Web of Science ®Google Scholar
• Stock SJ, Duthie L, Tremaine T, Elafin (SKALP/Trappin-2/proteinase inhibitor-3) is produced by the cervix in pregnancy and cervicovaginal levels are diminished in bacterial vaginosis. Reprod Sci 2009;16:1125-34
   PubMed Web of Science ®Google Scholar
• Iqbal SM, Ball TB, Levinson P, Elevated elafin/trappin-2 in the female genital tract is associated with protection against HIV acquisition. AIDS 2009;23:1669-77
   PubMed Web of Science ®Google Scholar
• Ness RB, Kip KE, Hillier SL, A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am J Epidemiol 2005;162:585-90
   PubMed Web of Science ®Google Scholar
• Reid G, Cook RL, Bruce AW. Examination of strains of lactobacilli for properties which may influence bacterial interference in the urinary tract. J Urol 1987;138:330-5
   PubMed Web of Science ®Google Scholar
• Mastromarino P, Brigidi P, Macchia S, Characterization and selection of vaginal Lactobacillus strains for the preparation of vaginal tablets. J Appl Microbiol 2002;93:884-93
   PubMed Web of Science ®Google Scholar
• McLean NW, Rosenstein IJ. Characterisation and selection of a Lactobacillus species to re-colonise the vagina of women with recurrent bacterial vaginosis. J Med Microbiol 2000;49:543-52
   PubMed Web of Science ®Google Scholar
• Osset J, Bartolome RM, Garcia E, Andreu A. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis 2001;183:485-91
   PubMed Web of Science ®Google Scholar
• Eschenbach DA, Davick PR, Williams BL, Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989;27:251-6
   PubMed Web of Science ®Google Scholar
• Reid G, Bruce AW, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 1995;23:32-45
   Google Scholar
• Gardiner GE, Heinemann C, Bruce AW, Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin Diag Lab Immunol 2002;9:92-6
   PubMedGoogle Scholar
• Kirjavainen PK, Laine RM, Carter D, Expression of anti-microbial defense factors in vaginal mucosa following exposure to Lactobacillus rhamnosus GR-1. Int J Probiotics 2008;3:99-106
   Google Scholar
• Burton JP, Cadieux P, Reid G. Improved understanding of the bacterial vaginal microbiota of women before and after probiotic instillation. Appl Environ Microbiol 2003;69:97-101
   PubMed Web of Science ®Google Scholar
• McGroarty JA, Reid G. Detection of a Lactobacillus substance which inhibits Escherichia coli. Can J Microbiol 1988;34:974-8
   PubMed Web of Science ®Google Scholar
• Klebanoff SJ, Hillier SL, Eschenbach DA, Waltersdorph AM. Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis 1991;164:94-100
   PubMed Web of Science ®Google Scholar
• Patterson JL, Girerd PH, Karjane NW, Jefferson KK. Effect of biofilm phenotype on resistance of Gardnerella vaginalis to hydrogen peroxide and lactic acid. Am J Obstet Gynecol 2007;197:170 e171-7
   PubMed Web of Science ®Google Scholar
• Saunders S, Bocking A, Challis J, Reid G. Effect of Lactobacillus challenge on Gardnerella vaginalis biofilms. Coll Surf B Biointerfaces 2007;55:138-42
   PubMed Web of Science ®Google Scholar
• Morelli L, Zonenenschain D, Del Piano M, Cognein P. Utilization of the intestinal tract as a delivery system for urogenital probiotics. J Clin Gastroenterol 2004;38:S107-10
   Web of Science ®Google Scholar
• Reid G, Bruce AW, Fraser N, Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 2001;30:49-52
   PubMed Web of Science ®Google Scholar
• Reid G, Charbonneau D, Erb J, Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 2003;35:131-4
   PubMed Web of Science ®Google Scholar
• Antonio MA, Rabe LK, Hillier SL. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis 2005;192:394-8
   PubMed Web of Science ®Google Scholar
• Bradshaw CS, Morton AN, Hocking J, High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006;193:1478-86
   PubMed Web of Science ®Google Scholar
• Oduyebo OO, Anorlu RI, Ogunsola FT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database Syst Rev 2009;3:CD006055
   Google Scholar
• Mastromarino P, Macchia S, Meggiorini L, Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin Microbiol Infect 2009;15:67-74
   PubMed Web of Science ®Google Scholar
• Hallen A, Jarstrand C, Pahlson C. Treatment of bacterial vaginosis with lactobacilli. Sex Transm Dis 1992;19:146-8
   PubMed Web of Science ®Google Scholar
• Rossi A, Rossi T, Bertini M, Caccia G. The use of Lactobacillus rhamnosus in the therapy of bacterial vaginosis. Evaluation of clinical efficacy in a population of 40 women treated for 24 months. Arch Gynecol Obstet 2010;281:1065-9
   PubMed Web of Science ®Google Scholar
• Anukam KC, Osazuwa E, Osemene GI, Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 2006;8:2772-6
   PubMed Web of Science ®Google Scholar
• Anukam K, Osazuwa E, Ahonkhai I, Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect 2006;8:1450-4
   PubMed Web of Science ®Google Scholar
• Martinez RC, Franceschini SA, Patta MC, Improved cure of bacterial vaginosis with single dose of tinidazole (2g) and Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can J Microbiol 2009;55:133-8
   PubMed Web of Science ®Google Scholar
• Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health 2008;8:3
   PubMedGoogle Scholar
• Eriksson K, Carlsson B, Forsum U, Larsson PG. A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta Derm Venereol 2005;85:42-6
   PubMed Web of Science ®Google Scholar
• Petricevic L, Witt A. The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis. BJOG 2008;115:1369-74
   PubMed Web of Science ®Google Scholar
• Shalev E, Battino S, Weiner E, Ingestion of yogurt containing Lactobacillus acidophilus compared with pasteurized yogurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 1996;5:593-6
   PubMedGoogle Scholar
• Marcone V, Calzolari E, Bertini M. Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences. New Microbiol 2008;31:429-33
   PubMed Web of Science ®Google Scholar
• Petricevic L, Unger FM, Viernstein H, Kiss H. Randomized, double-blind, placebo-controlled study of oral lactobacilli to improve the vaginal flora of postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2008;141:54-7
   PubMed Web of Science ®Google Scholar
• Beereport MAJ, Ter Riet M, Nys S, Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 versus trimethoprim-sulfamethoxazole (TMP/SMX) in the prevention of recurrent urinary tract infections (rUTIs) in postmenopausal women: a randomized double-blind non-inferiority trial. ICAAC 2009; abstract identifier: L1-1656a
   Google Scholar
• Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001 – 2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 2007;109:114-20
   PubMed Web of Science ®Google Scholar
• Hemmerling A, Harrison W, Schroeder A, Phase 1 dose-ranging safety trial of Lactobacillus crispatus CTV-05 for the prevention of bacterial vaginosis. Sex Transm Dis 2009;36:564-9
   PubMed Web of Science ®Google Scholar
• Antonio MA, Meyn LA, Murray PJ, Vaginal colonization by probiotic Lactobacillus crispatus CTV-05 is decreased by sexual activity and endogenous lactobacilli. J Infect Dis 2009;199:1506-13
   PubMed Web of Science ®Google Scholar
• Anukam KC, Osazuwa EO, Reid G, Katsivo MN. Receptivity for probiotic products among premenopausal female students in an African university. Sex Transm Dis 2004;31:460-4
   PubMed Web of Science ®Google Scholar
• Marrazzo JM, Cook RL, Wiesenfeld HC, Women's satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis. J Womens Health (Larchmt) 2006;15:1053-60
   PubMed Web of Science ®Google Scholar
• Bruce AW, Chadwick P, Hassan A, VanCott GF. Recurrent urethritis in women. Can Med Assoc J 1973;108:973-6
   PubMed Web of Science ®Google Scholar
• Chang TL, Chang CH, Simpson DA, Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Proc Natl Acad Sci USA 2003;100:11672-7
   PubMed Web of Science ®Google Scholar
• Liu JJ, Reid G, Jiang Y, Expression of HIV-inactivating proteins by recombinant human vaginal probiotic Lactobacillus reuteri RC-14. Cell Microbiol 2007;9:120-30
   PubMed Web of Science ®Google Scholar
• Vangelista L, Secchi M, Liu X, Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers. Antimicrob Agents Chemother 2010;54(7):2994-3001
   PubMed Web of Science ®Google Scholar